Abraxis Bioscience, Inc. v. Mayne Pharma (USA) Inc.

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

• affirming the district court’s finding of infringement by equivalence and stating that separate patentability of the accused pharmaceutical formulation did not outweigh substantial evidence of its equivalence

Source: CourtListener parenthetical corpus (CC0).